BioMarin Pharmaceutical, Inc. (BMRN)

zzlangerhans (99.48) Submitted: 6/11/08 10:37 PM : Start Price: $36.11 BMRN Score: -15.32

The recent pullback in share price makes Biomarin attractive since they haven't had any negative developments. Biomarin is definitely a solid company marketing very effective treatments, but now that they are profitable their share price is more vulnerable to being buffeted by economic forces. The wax and wane of optimism and pessimism will continue to keep BMRN in the 30-40 range until they clearly demonstrate a readiness to move upward to the next level. I feel better having BMRN in my portfolio than not, but I prefer holding them at 35 to holding them at 40.

Report this Post Replies: 0 | Reply | Permalink